Pomdoctor vs Ridgetech
POM and RDGT side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How POM and RDGT compare
Pomdoctor grew revenue faster over the last twelve months (16.7% versus 10.2% for Ridgetech).
Ridgetech scores higher on the StockData Score (7 against 1 for Pomdoctor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | POM | RDGT |
|---|---|---|
| Size and price | ||
| Share price | $1.62 | $1.06 |
| Change, 1 year | −98.3% | −99.8% |
| Change, 5 years | – | −100.0% |
| Beta (5Y) | 1.22 | 0.42 |
| Employees | 10K | 64 |
| StockData Score | ||
| Total score | 1 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 4 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 16.7% (better) | 10.2% |
| Revenue growth, 5Y average | – | −0.15% |
| Net income growth (TTM) | – | −112% |
| EPS growth (TTM) | – | −106% |
| Profitability | ||
| Gross margin | 13.1% (better) | 3.6% |
| Operating margin | −29.7% | −1.4% (better) |
| Net margin | – | −0.95% |
| FCF margin | −37.4% | −1.1% (better) |
| Return on equity | – | −4.2% |
| Return on invested capital | – | −8.7% |
| Financial health | ||
| Interest coverage | −30.1× | −27.8× (better) |
| Current ratio | 0.35 | 2.31 (better) |
| Piotroski F-score | – | 4 |
| Ownership | ||
| Held by institutions | 0.11% | 14.3% |
| Held by insiders | 28.1% | – |
| Insider net buying, 12 months | – | $45.6K |
| Superinvestors holding | – | 1 |
Go deeper
- POM stock overview
- POM income statement
- POM valuation and score
- RDGT stock overview
- RDGT income statement
- RDGT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.